KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$9.57
+0.29 (+3.13%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
+379.8% upside
Low Target
$25.11
Average Target
$45.92
High Target
$52.51
Current Price
$9.57
Current
$9.57
$9.57
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Scenario Analysis
Bear Case
$25.11
162.4%
Low target
Base Case
$45.92
+379.8%
Avg target
Bull Case
$52.51
+448.7%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$12.49
-23.4% from high
52-Week Low
$5.45
+75.6% from low
Target vs 52W High
$45.92
+267.7% vs high
Next Earnings Report
Aug 12, 2026 · After Market Close
2d
until earnings
EPS Est: $-0.90
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |